Skip to content
LinkeWire
  • Home
  • Submit Your Article
  • Blog
  • About Us

AbbVie

Cognizance Market Research

Global Androgen Replacement Therapy Market to Reach US$3.11 Billion by 2032, Driven by Aging Population and Rising Hypogonadism Awareness

June 1, 2025 by Cognizance Market Research

Androgen replacement therapy, often referred to as testosterone replacement therapy is a form of hormone therapy in which androgens, often testosterone, are supplemented or replaced. …

Read More

Categories News Tags AbbVie, androgen replacement therapy, Androgen Replacement Therapy Market, Bayer, Eli Lilly, Endo Pharmaceuticals, Hormone therapy, hypogonadism, JATENZO, low testosterone, menopause treatment, Pfizer, testosterone replacement therapy, TLANDO, TRT
Cognizance Market Research

Global Myasthenia Gravis Market to Reach US$2.89 Billion by 2030, Driven by Immunotherapies and Biologic Advancements

May 31, 2025 by Cognizance Market Research

Myasthenia gravis (MG) is a chronic, progressive, and uncommon neuromuscular disorder. In this autoimmune disorder in which the head, limb, spinal, ocular, and respiratory muscles …

Read More

Categories News Tags AbbVie, Alexion, Argenx, Astellas Pharma, autoimmune disease, Biologics, Corticosteroids, Immunosuppressants, immunotherapies, MG treatment, Myasthenia Gravis, Myasthenia Gravis Market, Neurology, neuromuscular disorder, rare diseases, Soliris (eculizumab)

Reach out to us for a consultation.

Let’s work together to start moving your business in the right direction.

Contact Us

© Linkewre

Privacy Policy Refund Policy Terms & Condition
  • Home
  • Submit Your Article
  • Blog
  • About Us